These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 15065856)

  • 1. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
    Gerken TA
    Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    Gerken TA; Zhang J; Levine J; Elhammer A
    J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
    Gerken TA; Gilmore M; Zhang J
    J Biol Chem; 2002 Mar; 277(10):7736-51. PubMed ID: 11777921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific core 1 O-glycosylation pattern of the porcine submaxillary gland mucin tandem repeat. Evidence for the modulation of glycan length by peptide sequence.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1998 Oct; 273(41):26580-8. PubMed ID: 9756896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.
    Gerken TA; Tep C; Rarick J
    Biochemistry; 2004 Aug; 43(30):9888-900. PubMed ID: 15274643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1997 Apr; 272(15):9709-19. PubMed ID: 9092502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I; Dowler T; Paulsen H
    Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synthesis of mucin-type O-glycans using saccharide primers comprising GalNAc-Ser and GalNAc-Thr residues.
    Sakura R; Nagai K; Yagi Y; Takahashi Y; Ide Y; Yagi Y; Yamamoto D; Mizuno M; Sato T
    Carbohydr Res; 2022 Jan; 511():108495. PubMed ID: 35026558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
    Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
    Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of O-glycan biosynthesis in human colon cancer tissues.
    Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
    Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of mucin synthesis: the peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 UDPgalactose:N-acetyl-alpha-galactosaminyl-R beta 3-galactosyltransferase.
    Brockhausen I; Möller G; Merz G; Adermann K; Paulsen H
    Biochemistry; 1990 Nov; 29(44):10206-12. PubMed ID: 2125490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-beta-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates.
    Granovsky M; Bielfeldt T; Peters S; Paulsen H; Meldal M; Brockhausen J; Brockhausen I
    Eur J Biochem; 1994 May; 221(3):1039-46. PubMed ID: 8181460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and biosynthesis of human salivary mucins.
    Zalewska A; Zwierz K; Zółkowski K; Gindzieński A
    Acta Biochim Pol; 2000; 47(4):1067-79. PubMed ID: 11996097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of O-glycosylated C-terminal leucine zipper domain of human salivary mucin (MUC7).
    Narasimhamurthy S; Naganagowda GA; Janagani S; Gururaja TL; Levine MJ
    J Biomol Struct Dyn; 2000 Aug; 18(1):145-54. PubMed ID: 11021659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic determination of the peptide acceptor preferences for the human UDP-Gal:glycoprotein-alpha-GalNAc beta 3 galactosyltransferase (T-synthase).
    Perrine C; Ju T; Cummings RD; Gerken TA
    Glycobiology; 2009 Mar; 19(3):321-8. PubMed ID: 19073881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.
    Revoredo L; Wang S; Bennett EP; Clausen H; Moremen KW; Jarvis DL; Ten Hagen KG; Tabak LA; Gerken TA
    Glycobiology; 2016 Apr; 26(4):360-76. PubMed ID: 26610890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.
    Naganagowda GA; Gururaja TL; Satyanarayana J; Levine MJ
    J Pept Res; 1999 Oct; 54(4):290-310. PubMed ID: 10532235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.